Downstream process development platform for biosimilar monoclonal antibody drug molecule
dc.contributor.advisor | supervisor Özge Can | |
dc.contributor.author | Baş, Dilara | |
dc.date.accessioned | 2023-02-20T13:26:06Z | |
dc.date.available | 2023-02-20T13:26:06Z | |
dc.date.issued | 2020-01-01 | |
dc.department | Department of Medical Biotechnology | |
dc.format.extent | xii, 76 s. + 1 CD-ROM (4 3/4 in.) | |
dc.identifier.uri | https://hdl.handle.net/11443/833 | |
dc.institution | Institute of Health Sciences | |
dc.language.iso | en | |
dc.publisher | Acıbadem Mehmet Ali Aydınlar Üniversitesi | |
dc.subject | Medikal biyoteknoloji. | |
dc.subject | Medical biotechnology. | |
dc.title | Downstream process development platform for biosimilar monoclonal antibody drug molecule | |
dc.type | YL Tezi |
Files
Original bundle
1 - 1 of 1
- Name:
- Downstream process development platform for biosimilar monoclonal antibody drug molecule.pdf
- Size:
- 2.17 MB
- Format:
- Adobe Portable Document Format